| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Masahiko Kawano, Hidehiro Oshibuchi, Takaaki Kawano, Hiroyuki Muraoka, Takahiro Tsutsumi, Makiko Yamada, Ken Inada, Jun Ishigook. Dopamine dynamics during emotional cognitive processing: Implications of the specific actions of clozapine compared with haloperidol. European journal of pharmacology. vol 781. 2017-03-08. PMID:27085900. |
however, the specific dopaminergic state-dependent action of clozapine on both basal dopamine levels and stress-induced dopamine release may be the underlying mechanism for its superior clinical effect on emotional cognitive processing in patients with schizophrenia. |
2017-03-08 |
2023-08-13 |
rat |
| G Remington, J Lee, O Agid, H Takeuchi, G Foussias, M Hahn, G Fervaha, L Burton, V Powel. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use. Expert opinion on drug safety. vol 15. issue 9. 2017-02-27. PMID:27207070. |
clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use. |
2017-02-27 |
2023-08-13 |
Not clear |
| Mugtaba Osman, Vekneswaran Devada. Clozapine-induced dysphagia with secondary substantial weight loss. BMJ case reports. vol 2016. 2017-02-27. PMID:27543610. |
an 18-year-old single man with an established diagnosis of treatment-resistant paranoid schizophrenia recovered well on a therapeutic dose of clozapine. |
2017-02-27 |
2023-08-13 |
Not clear |
| Peter Manu, Eugene Grudnikof. Clozapine for Treatment-Resistant Schizophrenia. American journal of therapeutics. vol 23. issue 5. 2017-02-27. PMID:27603450. |
clozapine for treatment-resistant schizophrenia. |
2017-02-27 |
2023-08-13 |
Not clear |
| Tarun Bastiampillai, Arun Gupta, Stephen Alliso. FDA changes clozapine monitoring guidelines: Implications for worldwide practice. Asian journal of psychiatry. vol 21. 2017-02-13. PMID:27208449. |
these changes will allow a greater number of patients with schizophrenia in usa to be continued on clozapine. |
2017-02-13 |
2023-08-13 |
Not clear |
| Michiko Fujimoto, Ryota Hashimoto, Hidenaga Yamamori, Yuka Yasuda, Kazutaka Ohi, Hirotsugu Iwatani, Yoshitaka Isaka, Masatoshi Taked. Clozapine improved the syndrome of inappropriate antidiuretic hormone secretion in a patient with treatment-resistant schizophrenia. Psychiatry and clinical neurosciences. vol 70. issue 10. 2017-02-13. PMID:27539233. |
clozapine improved the syndrome of inappropriate antidiuretic hormone secretion in a patient with treatment-resistant schizophrenia. |
2017-02-13 |
2023-08-13 |
Not clear |
| Antonio Bruno, Gianluca Pandolfo, Manuela Crucitti, Simona Lorusso, Rocco Antonio Zoccali, Maria Rosaria Anna Muscatell. Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study. Clinical neuropharmacology. vol 39. issue 6. 2017-01-23. PMID:27404738. |
acetyl-l-carnitine augmentation of clozapine in partial-responder schizophrenia: a 12-week, open-label uncontrolled preliminary study. |
2017-01-23 |
2023-08-13 |
Not clear |
| Antonio Bruno, Gianluca Pandolfo, Manuela Crucitti, Simona Lorusso, Rocco Antonio Zoccali, Maria Rosaria Anna Muscatell. Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study. Clinical neuropharmacology. vol 39. issue 6. 2017-01-23. PMID:27404738. |
this was the first 12-week, open-label, uncontrolled trial aimed at exploring the efficacy of acetyl-l-carnitine (alc) add-on pharmacotherapy on clinical symptoms and cognitive functioning in 15 schizophrenia patients with suboptimal clinical response despite receiving clozapine (clz) monotherapy at the highest tolerated dosage. |
2017-01-23 |
2023-08-13 |
Not clear |
| Junji Gon, Yasushi Takehisa, Yuji Yada, Yoshiki Kishi, Etsuko Oshima, Yukitoshi Takahashi, Manabu Takak. Encephalitis With Antibodies to GluN2B During Administration of Clozapine. Clinical neuropharmacology. vol 39. issue 6. 2017-01-23. PMID:27482955. |
clozapine's immunomodulatory properties may contribute to its effect on schizophrenia as well as various adverse effects. |
2017-01-23 |
2023-08-13 |
Not clear |
| Junji Gon, Yasushi Takehisa, Yuji Yada, Yoshiki Kishi, Etsuko Oshima, Yukitoshi Takahashi, Manabu Takak. Encephalitis With Antibodies to GluN2B During Administration of Clozapine. Clinical neuropharmacology. vol 39. issue 6. 2017-01-23. PMID:27482955. |
we experienced a patient who developed refractory schizophrenia that mimicked an exacerbation of encephalitis with antibodies to n-methyl-d-aspartate-type glutamate receptor (glun2b) after administration of clozapine for 26 days. |
2017-01-23 |
2023-08-13 |
Not clear |
| Junji Gon, Yasushi Takehisa, Yuji Yada, Yoshiki Kishi, Etsuko Oshima, Yukitoshi Takahashi, Manabu Takak. Encephalitis With Antibodies to GluN2B During Administration of Clozapine. Clinical neuropharmacology. vol 39. issue 6. 2017-01-23. PMID:27482955. |
when we administer clozapine to patients with refractory schizophrenia, we should be careful to differentiate between a diagnosis of refractory schizophrenia and encephalitis with antibodies to glun2b. |
2017-01-23 |
2023-08-13 |
Not clear |
| Jay Carruthers, Marleen Radigan, Matthew D Erlich, Gyojeong Gu, Rui Wang, Eric Y Frimpong, Susan M Essock, Mark Olfson, Enrico G Castillo, Gregory A Miller, Lloyd I Sederer, T Scott Strou. An Initiative to Improve Clozapine Prescribing in New York State. Psychiatric services (Washington, D.C.). vol 67. issue 4. 2017-01-17. PMID:26725299. |
clozapine remains the only medication approved for treatment-resistant schizophrenia. |
2017-01-17 |
2023-08-13 |
Not clear |
| Jay Carruthers, Marleen Radigan, Matthew D Erlich, Gyojeong Gu, Rui Wang, Eric Y Frimpong, Susan M Essock, Mark Olfson, Enrico G Castillo, Gregory A Miller, Lloyd I Sederer, T Scott Strou. An Initiative to Improve Clozapine Prescribing in New York State. Psychiatric services (Washington, D.C.). vol 67. issue 4. 2017-01-17. PMID:26725299. |
from 2009 to 2013, in the absence of a well-funded pharmaceutical marketing campaign, the proportion of new clozapine trials among all new outpatient antipsychotic trials increased 40% among adult new york medicaid recipients with a diagnosis of schizophrenia. |
2017-01-17 |
2023-08-13 |
Not clear |
| Omer Saatcioglu, Murat Kalkan, Nurhan Fistikci, Sakire Erek, Kasim Candas Kili. Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia. The Psychiatric quarterly. vol 87. issue 2. 2017-01-09. PMID:26174109. |
our findings showed that the duration of illness, high scores of bmi, use of clozapine or concurrent use of typical and atypical antipsychotics, depressive and negative symptoms of schizophrenia were significant risk factors for the development of ms. |
2017-01-09 |
2023-08-13 |
Not clear |
| Cana Aksoy Poyraz, Armağan Özdemir, Nazife Gamze Usta Sağlam, Şenol Turan, Burç Çağrı Poyraz, Nesrin Tomruk, Alaattin Dura. Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia. The Psychiatric quarterly. vol 87. issue 2. 2017-01-09. PMID:26433727. |
rapid clozapine titration in patients with treatment refractory schizophrenia. |
2017-01-09 |
2023-08-13 |
Not clear |
| Cana Aksoy Poyraz, Armağan Özdemir, Nazife Gamze Usta Sağlam, Şenol Turan, Burç Çağrı Poyraz, Nesrin Tomruk, Alaattin Dura. Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia. The Psychiatric quarterly. vol 87. issue 2. 2017-01-09. PMID:26433727. |
the aim of this study is to evaluate the safety and effectiveness of rapid clozapine titration in patients with schizophrenia in hospital settings. |
2017-01-09 |
2023-08-13 |
Not clear |
| Cana Aksoy Poyraz, Armağan Özdemir, Nazife Gamze Usta Sağlam, Şenol Turan, Burç Çağrı Poyraz, Nesrin Tomruk, Alaattin Dura. Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia. The Psychiatric quarterly. vol 87. issue 2. 2017-01-09. PMID:26433727. |
we conducted a retrospective two-center cohort study to compare the safety and effectiveness of clozapine with different titration rates in treatment-refractory patients with schizophrenia. |
2017-01-09 |
2023-08-13 |
Not clear |
| Cana Aksoy Poyraz, Armağan Özdemir, Nazife Gamze Usta Sağlam, Şenol Turan, Burç Çağrı Poyraz, Nesrin Tomruk, Alaattin Dura. Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia. The Psychiatric quarterly. vol 87. issue 2. 2017-01-09. PMID:26433727. |
however starting clozapine earlier together with rapid titration has significantly shortened the length of hospital stay in patients with treatment refractory schizophrenia. |
2017-01-09 |
2023-08-13 |
Not clear |
| Maurício Scopel Hoffmann, Lucas Mendes Oliveira, Maria Inês Rodrigues Lobato, Paulo Belmonte-de-Abre. Heat stroke during long-term clozapine treatment: should we be concerned about hot weather? Trends in psychiatry and psychotherapy. vol 38. issue 1. 2017-01-09. PMID:27074342. |
to describe the case of a patient with schizophrenia on clozapine treatment who had an episode of heat stroke. |
2017-01-09 |
2023-08-13 |
Not clear |
| Marloes R Overbeeke, Marieke M Beex-Oosterhuis, Ellen Graveland, Jannie N den Hoed-van Wijk, Arthur R Van Goo. Successful clozapine continuation during chemotherapy for the treatment of malignancy: a case report. International journal of clinical pharmacy. vol 38. issue 2. 2017-01-06. PMID:26951123. |
a 45-year-old male diagnosed with schizophrenia used clozapine together with zuclopenthixol for more than 15 years. |
2017-01-06 |
2023-08-13 |
Not clear |